Senores Pharmaceuticals, Inc has acquired a 51 percent membership interest in Zoraya Pharmaceuticals, based in US. The acquisition, formalised through a Limited Liability Company Agreement (LLCA) dated November 4, 2025, makes Zoraya Pharmaceuticals a step-down subsidiary of Senores Pharma.

Zoraya Pharmaceuticals, incorporated on October 15, 2025, operates in the pharmaceutical sector. As a newly established company, it does not yet have turnover figures. The move aligns with Senores Pharma’s strategic objective to strengthen its presence and operational base in the US market.